ProMIS Neurosciences Inc. (PMN) stock

PMNNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30

$3.29−0.19 (-5.46%)

Close on Nov 13, 2026Market cap $29.50MP/E –Yield –

ProMIS Neurosciences gross margin

Gross margin is gross profit as a percentage of revenue.

ProMIS Neurosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?